China slams US bill targeting biotech firms as 'discriminatory'

Reuters09-10

BEIJING, Sept 10 (Reuters) - The United State's passage of a bill that aims to restrict business with Wuxi AppTec

, BGI and other biotech firms was a "discriminatory" measure against Chinese companies, China's foreign ministry said on Tuesday.

China urges the U.S. to respect market principles and trade rules, stop pushing forward the bill and misusing all kinds of excuses to suppress Chinese companies, ministry spokesperson Mao Ning said at a press briefing.

(Reporting by Colleen Howe and Beijing Newsroom; Editing by Christian Schmollinger)

((Ethan.Wang@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment